Gad, Shayne C., 1948-
Safety pharmacology in pharmaceutical development approval and post marketing surveillance / [electronic resource] : Shayne C. Gad. - 2nd ed. - Boca Raton, Fla. : CRC Press, 2012. - xv, 197 p. : ill.
Rev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.
Includes bibliographical references and index.
ch. 1. Safety pharmacology : background, history, issues, and concerns -- ch. 2. Regulatory requirements : ICH, FDA, EMA, and Japan -- ch. 3. Principles of screening and study design -- ch. 4. Cardiovascular system -- ch. 5. Central nervous system -- ch. 6. Respiratory system -- ch. 7. Renal function -- ch. 8. The gastrointestinal system -- ch. 9. The immune system.
"This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher.
Mode of access: World Wide Web.
9781439845684 (ebook : PDF)
Drug development.
Drug approval.
Pharmacology.
Electronic books.
Safety pharmacology in pharmaceutical development approval and post marketing surveillance / [electronic resource] : Shayne C. Gad. - 2nd ed. - Boca Raton, Fla. : CRC Press, 2012. - xv, 197 p. : ill.
Rev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.
Includes bibliographical references and index.
ch. 1. Safety pharmacology : background, history, issues, and concerns -- ch. 2. Regulatory requirements : ICH, FDA, EMA, and Japan -- ch. 3. Principles of screening and study design -- ch. 4. Cardiovascular system -- ch. 5. Central nervous system -- ch. 6. Respiratory system -- ch. 7. Renal function -- ch. 8. The gastrointestinal system -- ch. 9. The immune system.
"This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher.
Mode of access: World Wide Web.
9781439845684 (ebook : PDF)
Drug development.
Drug approval.
Pharmacology.
Electronic books.